Company intelligence / Profile preview

Jinghui Pharmaceutical

Ownership: Private
Development stage: Preclinical

Overview

Jinghui Pharmaceutical, officially known as Xianning Jinghui Pharmaceutical Enterprise Co. Ltd., is a Chinese pharmaceutical manufacturer established in 1991, specializing in the production and trade of active pharmaceutical ingredients such as pyridoxine (vitamin B6) and various steroidal compounds. The company supplies both domestic and international markets with raw materials for pharmaceuticals, particularly focusing on vitamins and steroids.

Therapeutic areas: Metabolic DisordersImmunology
Modalities: Small molecule
Industry: Chemicals & Materials

Drug pipeline

4 assets

betamethasone

Commercial

Indications: Anti-inflammatory

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jinghui Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinghui Pharmaceutical.

Explore the full profile